ACMT Toxicology Visual Pearl – Who Toad You to Lick It?

When people intentionally lick this toad, which toxin can they be exposed to?
- Bufodienolides
- Ciguatoxin
- Mescaline
- Psilocybin
[Image by Spencer B. via iNaturalist]

When people intentionally lick this toad, which toxin can they be exposed to?
[Image by Spencer B. via iNaturalist]

Read this tutorial on the use of point of care ultrasonography (POCUS) for pediatric musculoskeletal evaluation. Then test your skills on the ALiEMU course page to receive your PEM POCUS badge worth 2 hours of ALiEMU course credit.
A 13-year-old female with no past medical history presents to the emergency department with pain and swelling to her left knee. The pain started 3 days ago, with the pain worsening and swelling noted on the day prior to arrival. She can bear weight but has a limp. She has had no other current or past joint pain or swelling, no known trauma, no fever or other infectious symptoms, no recent travel, and no known insect or tick bites. She spent the summer at camp in the northeast United States. Her vaccines are up to date.
On arrival, her vital signs are:
| Vital Sign | Finding |
|---|---|
| Temperature | 37.3 C |
| Heart rate | 109 bpm |
| Blood pressure | 117/74 |
| Respiratory rate | 20 |
| Oxygen saturation (room air) | 99% |
On physical examination, she is well appearing and in no acute distress. Her exam is significant for left knee swelling and tenderness to palpation anteriorly with decreased knee flexion due to pain. She has no redness, warmth, or numbness around her knee. She has an antalgic gait but can bear weight.
Given her pain and swelling of her left knee, blood tests and X-rays are ordered, and orthopedics is consulted. You decide to perform a musculoskeletal point-of-care ultrasound (MSK POCUS) examination.
A musculoskeletal POCUS of the left knee with a linear, high-frequency probe demonstrated a joint effusion in the suprapatellar bursa with internal septations (Figures 45 and 46).

Figure 45. Left knee POCUS demonstrating a joint effusion in the suprapatellar bursa (L) and internal septations within the effusion (R).
Figure 46. Longitudinal scan of the left knee showing the joint effusion with internal septations.
Initial laboratory studies showed a white blood cell count of 10 × 109/L, ESR 69 mm/hr, and CRP 32 mg/L. Knee radiographs were negative for fracture. Orthopedics performed an arthrocentesis that yielded synovial fluid with 52,000 white blood cells/µL, raising concern for septic arthritis.
The patient was admitted, started on intravenous antibiotics, and taken to the operating room for incision, drainage, and washout. Joint fluid cultures returned negative, but Lyme serologies returned positive. She was transitioned to a 28-day course of doxycycline for Lyme arthritis.

Read this tutorial on the use of point of care ultrasonography (POCUS) for pediatric first-trimester pregnancy evaluation. Then test your skills on the ALiEMU course page to receive your PEM POCUS badge worth 2 hours of ALiEMU course credit.
A 17-year-old female with a past medical history of pelvic inflammatory disease, presents as a walk-in from triage with lower abdominal pain and vaginal bleeding that started this morning. She has soaked through three pads since this morning without the passage of clots. She reports mild nausea, and dizziness. She denies any fevers, chills, chest pain, shortness of breath, vomiting, or decreased appetite. She is currently sexually active with one male partner in a monogamous relationship and does not use protection. Her menstrual periods are irregular and she is unsure of her last menstrual period.
On arrival, her vital signs are:
| Vital Sign | Finding |
|---|---|
| Temperature | 37 C |
| Heart rate | 94 bpm |
| Blood pressure | 98/62 |
| Respiratory rate | 14 |
| Oxygen saturation (room air) | 99% |
You use a curvilinear abdominal probe (Figure 16) and endocavitary probe (Figure 17) and visualize the following:

Figure 16. Right adnexal view showing a “ring of fire” sign suggestive of an ectopic pregnancy

Figure 17. Sagittal view of uterus showing the absence of an intrauterine pregnancy
Given her initial low blood pressure and an obstetric ultrasound concerning for an ectopic pregnancy, you decide to perform a FAST exam, and you see free fluid in the hepatorenal recess.

Figure 18. Right upper quadrant abdominal view, showing free fluid in Morison’s pouch
Serum labs show the following:
The obstetrics and gynecology team is consulted for a likely ectopic pregnancy, and the patient is taken to the OR for an emergent laparotomy.

Ingestion of the pictured mushroom is most associated with which toxicity?
[Image credit to William Morris via Creative Commons]
(more…)

For years, clinicians and researchers have debated a fundamental question in pediatric emergency care: does the type of fluid used in pediatric sepsis resuscitation matter?
The PRoMPT BOLUS trial was designed to answer this question. Conducted across 47 international sites in 5 countries and enrolling more than 9,000 children, this large, pragmatic randomized trial compared 0.9% saline with balanced crystalloids in children treated for suspected septic shock.
The results have just been released. Across a wide range of clinically meaningful outcomes (including kidney injury, mortality, and recovery), there was no difference between fluid types.
Sepsis remains a major global health concern, affecting approximately 50 million people each year, with children accounting for nearly half of these cases. Early fluid resuscitation is a cornerstone of treatment, making the choice of fluid a critical and historically debated decision.
Two primary types of crystalloid fluids are used in practice:
Prior research raised concerns that saline could contribute to metabolic acidosis and kidney injury, while balanced fluids were associated with improved outcomes in some adult and smaller pediatric studies. However, the pediatric literature remained inconsistent, with observational studies reaching conflicting conclusions. As a result, guidelines offered only weak recommendations favoring balanced fluids and called for more definitive trials.
PRoMPT BOLUS was designed to fill this gap.
This trial used a pragmatic, randomized design (NS vs. balanced fluids), intentionally embedded into routine clinical care. Pragmatic trials evaluate clinical interventions within typical practice, rather than highly controlled clinical settings. By incorporating fluid randomization without modifying additional aspects of clinical practice, this approach allowed investigators to study fluid choice in real-world conditions across diverse healthcare systems. PRoMPT BOLUS was a collaborative effort across multiple networks including PECARN (Pediatric Emergency Care Applied Research Network), PERC (Pediatric Emergency Research Canada), and PREDICT (Paediatric Research in Emergency Departments International Collaborative).
Children ages 2 months to <18 years were eligible if clinicians suspected sepsis and were planning to treat with more than one fluid bolus for abnormal perfusion consistent with septic shock. They were randomized to receive either balanced fluids or 0.9% saline, with clinicians otherwise managing care as they normally would.
The primary outcome was MAKE30 (Major Adverse Kidney Events within 30 days), a composite that includes mortality, need for renal replacement therapy, or persistent kidney dysfunction at hospital discharge or 30 days, whichever came first.
This pragmatic approach was critical to the study’s success. It allowed for:
The primary outcome, MAKE30, occurred at nearly identical rates in both groups:
This difference was neither statistically nor clinically significant. There were also no differences in any of the individual MAKE30 components between treatment groups.
Similarly, there were no meaningful differences in:
Together, these findings strongly support the conclusion that both fluids are equally safe and effective.
Although there were measurable and statistically significant biochemical differences between groups (such as higher rates of hyperchloremia and hypernatremia with saline and hyperlactatemia with balanced fluids), these changes did not translate into clinically meaningful outcomes.
Subgroup analyses across patient characteristics, illness severity, and total fluid volume showed no differences in outcomes. While there was a non-significant trend suggesting potential benefit of balanced fluids in the most severely ill patients, the study was not powered to confirm this finding.
The results of PRoMPT BOLUS can be distilled into several key conclusions:
Importantly, while the study cannot fully exclude a benefit of balanced fluids in the sickest patients, it provides strong evidence that for children presenting to the ED with suspected sepsis, either fluid is an appropriate choice.
These findings have immediate and meaningful implications for clinical practice.
First, they simplify decision-making. Clinicians can focus on timely recognition and treatment of children with suspected sepsis, and engage in fluid resuscitation with fluids that make sense for the clinical scenario.
Second, the results support flexibility in care. Fluid choice can now be guided by:
While the study is robust, several limitations should be considered.
The overall incidence of MAKE30 was lower than expected (~3% vs. an anticipated ~6%), which may reflect a less severely ill population than initially projected. This could limit the ability to detect small differences between groups.
Additionally, although subgroup analyses suggested a possible benefit of balanced fluids in more severely ill patients, the study was not powered to draw definitive conclusions in this population.
The PRoMPT BOLUS trial provides the strongest evidence to date addressing fluid choice in children presenting to the ED with suspected sepsis. Both 0.9% saline and balanced crystalloids are safe and effective for resuscitation in children with suspected septic shock.

What type of burn may not develop findings shown until days to weeks after the exposure?
[Image generated via Google Gemini]

Welcome to the AIR Non-ACS Cardiology Module! After carefully reviewing all relevant posts in the past 12 months from the top 50 sites of the Digital Impact Factor [1], the ALiEM AIR Team is proud to present the highest quality online content related to non-ACS cardiology emergencies in the Emergency Department. 9 blog posts met our standard of online excellence and were approved for residency training by the AIR Series Board. More specifically, we identified 6 AIR and 3 Honorable Mentions. We recommend programs give 5 hours of III credit for this module.
In an effort to truly emphasize the highest quality posts, we have 2 subsets of recommended resources. The AIR stamp of approval is awarded only to posts scoring above a strict scoring cut-off of ≥30 points (out of 35 total), based on our scoring instrument. The other subset is for “Honorable Mention” posts. These posts have been flagged by and agreed upon by AIR Board members as worthwhile, accurate, unbiased, and appropriately referenced despite an average score.
Want asynchronous Individualized Interactive Instruction (III) credit?
Take the AIR quiz at ALiEMU. Free, 1-time login required.
| Site | Article | Author | Date | Label |
|---|---|---|---|---|
| EMCrit | Supraventricular Tachycardia | Dr. Josh Farkas | January 5, 2025 | AIR |
| EMCrit | Right Ventricular Failure | Dr. Josh Farkas | March 21, 2025 | AIR |
| EMCrit | Valvular Heart Disease | Dr. Josh Farkas | January 27, 2025 | AIR |
| EMCrit | Antiarrhythmics | Dr. Josh Farkas | January 8, 2025 | AIR |
| EM Cases | Acute heart failure risk stratification and disposition | Dr. Anton Helman | August 19, 2025 | AIR |
| EMCrit | SCAPE (sympathetic crashing acute pulmonary edema) | Dr. Josh Farkas | January 30, 2025 | AIR |
| RCEMlearning | Cardiogenic Pulmonary Oedema | Dr. Victoria Henson | May 30, 2025 | HM |
| EMCrit | Acute Pericarditis | Dr. Josh Farkas | September 20, 2025 | HM |
| EMCrit | Acute Myocarditis and evaluation of newly discovered HFrEF | Dr. Josh Farkas | October 1, 2024 | HM |
(AIR = Approved Instructional Resource; HM = Honorable Mention)
If you have any questions or comments on the AIR series, or this AIR module, please contact us!